Given the ability of MC4R inhibition to suppress tumor proliferation and promote apoptosis, particularly in combination with chemotherapeutic agents, this approach could offer a much-needed targeted treatment option for these challenging and often resistant cancer types. This evidence concerns the gene MC4R and neoplasm.